These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4196721)

  • 21. Inhibition of immediate hypersensitivity reactions in the rat by ICI 74,917 and disodium cromoglycate.
    Evans DP; Marshall PW; Thomson DS
    Int Arch Allergy Appl Immunol; 1975; 49(4):417-27. PubMed ID: 51008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacological studies on oxatomide (KW-4354): (1) Effect on passive cutaneous anaphylaxis (PCA)].
    Ohmori K; Ishii H; Hirayama T; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):251-60. PubMed ID: 6130032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationships of disodium cromoglycate and some related compounds.
    Cairns H; Fitzmaurice C; Hunter D; Johnson PB; King J; Lee TB; Lord GH; Minshull R; Cox JS
    J Med Chem; 1972 Jun; 15(6):583-9. PubMed ID: 4624147
    [No Abstract]   [Full Text] [Related]  

  • 24. [[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
    Terasawa M; Goto K; Maruyama Y
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):417-27. PubMed ID: 6219052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indolo[2,1-c][1,4]benzodiazepines: a new class of antiallergic agents.
    Ho CY; Hageman WE; Persico FJ
    J Med Chem; 1986 Jun; 29(6):1118-21. PubMed ID: 2872333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of homologous passive cutaneous anaphylaxis (PCA) by disodium cromoglycate-related compounds.
    Koda A; Sakamoto K; Yanagihara Y
    Jpn J Pharmacol; 1980 Aug; 30(4):437-47. PubMed ID: 6162986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiallergic activity of alkyl substituted pyrazolo[3, 4-d]pyrimidine (compound 88-765).
    Gupta PP; Srimal RC; Avasthi K; Garg N; Chandra T; Bhakuni DS
    Indian J Exp Biol; 1995 Jan; 33(1):38-40. PubMed ID: 9135673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological activity of biscoumarinoxy-, bis(1,2-benzisoxazoloxy) & bisbenzofuranoxy-alkanes & their unsymmetric compounds: disodium cromoglycate analogs.
    Thakar KA; Dumir AB
    Indian J Exp Biol; 1978 Jun; 16(6):732-4. PubMed ID: 81180
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-allergic activities of a new benzopyranopyridine derivative Y-12,141 in rats.
    Goto K; Terasawa M; Maruyama Y
    Int Arch Allergy Appl Immunol; 1979; 59(1):13-9. PubMed ID: 87373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of allergic reactions by cromoglycate and by a new anti-allergy drug U-42,585E. I. Activity in rats.
    Johnson HG; VanHout CA; Wright JB
    Int Arch Allergy Appl Immunol; 1978; 56(5):416-23. PubMed ID: 75851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines.
    Musser JH; Jones H; Sciortino S; Bailey K; Coutts SM; Khandwala A; Sonnino-Goldman P; Leibowitz M; Wolf P; Neiss ES
    J Med Chem; 1985 Sep; 28(9):1255-9. PubMed ID: 2411926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of rat passive cutaneous anaphylaxis by 3-(tetrazol-5-yl)quinolines.
    Erickson EH; Hainline CF; Lenon LS; Matson CJ; Rice TK; Swingle KE; Van Winkle M
    J Med Chem; 1979 Jul; 22(7):816-23. PubMed ID: 109613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo activity profile of RHC 2851: a new orally effective antiallergic agent.
    Khandwala A; Carlson R; Dally-Meade V; Donigi-Ruzza D
    J Immunopharmacol; 1983; 5(4):311-32. PubMed ID: 6199431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The activity of sodium cromoglycate analogues in human lung in vitro: a comparison with rat passive cutaneous anaphylaxis and clinical efficacy.
    Church MK; Gradidge CF
    Br J Pharmacol; 1980 Oct; 70(2):307-11. PubMed ID: 6159030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of disodium cromoglycate on cutaneous basophil anaphylaxis.
    Golden HW; Crean GL; Iacuzio DA; Otterness IG
    J Immunol; 1986 Sep; 137(5):1495-503. PubMed ID: 2427571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunopharmacological studies on TBX, a new antiallergic drug (1). Inhibitory effects on passive cutaneous anaphylaxis in rats and guinea pigs.
    Yanagihara Y; Kasai H; Kawashima T; Shida T
    Jpn J Pharmacol; 1988 Sep; 48(1):91-101. PubMed ID: 2462074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunopharmacologic properties of WY-16,922, a new orally effective antiallergic agent.
    Rosenthale ME; Begany AJ; Dervinis A; Sellstedt J; Guinosso C; Gluckman MI
    J Pharmacol Exp Ther; 1976 Apr; 197(1):153-62. PubMed ID: 57234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of predosing with Y-12,141 on its antiallergic activity. --Studies on anti-allergic agents(IV)-- (author's transl)].
    Goto K; Terasawa M; Komori A; Maruyama Y
    Nihon Yakurigaku Zasshi; 1981 Feb; 77(2):123-9. PubMed ID: 6786963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental pharmacological studies in the development of disodium cromoglycate].
    Cox JS
    Alergia; 1972 Aug; 20(1):35-46. PubMed ID: 4628933
    [No Abstract]   [Full Text] [Related]  

  • 40. Disodium cromoglycate. Mode of action and its possible relevance to the clinical use of the drug.
    Cox JS
    Br J Dis Chest; 1971 Oct; 65(4):189-204. PubMed ID: 4400180
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.